JP Patent

JP2018520114A — イソトレチノインの１日１回経口医薬組成物

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2018-07-26 · 8y expired

What this patent protects

本発明は、イソトレチノインの１日１回経口医薬組成物及びその調製方法に関する。

USPTO Abstract

本発明は、イソトレチノインの１日１回経口医薬組成物及びその調製方法に関する。

Drugs covered by this patent

treprostinil-diolamine (TREPROSTINIL DIOLAMINE)

Patent Metadata

Patent number: JP2018520114A
Jurisdiction: JP
Classification: —
Expires: 2018-07-26
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.